{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:04:40Z","timestamp":1789646680374,"version":"4.0.0"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF23SA0087056"],"award-info":[{"award-number":["NNF23SA0087056"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Digit Health"],"accepted":{"date-parts":[[2026,8,31]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Hospitals are increasingly shifting from being passive purchasers of artificial intelligence (AI) systems to active developers of medical AI, particularly in the form of in-hospital machine learning tools tailored to local clinical needs. This paper examines how the European Union (EU) and the USA regulate in-hospital-developed AI-based medical devices, focusing on the legal and institutional conditions that shape innovation, oversight and diffusion. Through a comparative analysis across three dimensions\u2014responsiveness to clinical need, distribution of innovative capacity and pathways for scaling and diffusion\u2014the paper shows that both systems enable hospital-based innovation but embed it in different regulatory logics. The EU adopts a structured model that treats hospitals as regulated innovators operating under defined institutional obligations, whereas the USA relies on a more permissive and less institutionally differentiated framework in which hospital innovation emerges as a by-product of general software regulation.<\/jats:p>","DOI":"10.1136\/bmjdh-2026-000105","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:45:20Z","timestamp":1789645520000},"page":"e000105","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["When hospitals build their own AI: a comparison of the EU and US regulatory framework"],"prefix":"10.1136","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6618-5963","authenticated-orcid":false,"given":"Sofia","family":"Palmieri","sequence":"first","affiliation":[{"name":"Harvard Law School, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Minssen","sequence":"additional","affiliation":[{"name":"Centre for Advanced Studies in Bioscience Innovation Law (CeBIL), University of Copenhagen, Copenhagen, Capital Region of Denmark, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Glenn","family":"Cohen","sequence":"additional","affiliation":[{"name":"Harvard Law School, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2026091704450875000_2.1.e000105.1","unstructured":"Hospital trends in the use, Evaluation, and Governance of Predictive AI, 2023-2024. Office of the National Coordinator for Health Information Technology (ASTP\/ONC); 2025. Available: https:\/\/healthit.gov\/data\/data-briefs\/hospital-trends-use-evaluation-and-governance-predictive-ai-2023-2024\/"},{"key":"2026091704450875000_2.1.e000105.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjinnov-2023-001150"},{"key":"2026091704450875000_2.1.e000105.3","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-024-01037-4","article-title":"Why do probabilistic clinical models fail to transport between sites","volume":"7","author":"Lasko","year":"2024","journal-title":"NPJ Digit Med"},{"key":"2026091704450875000_2.1.e000105.4","unstructured":"Regulation (EU) 2017\/745 of the European Parliament and of the Council of 5 April 2017 on Medical Devices . Amending Directive 2001\/83\/EC, Regulation (EC) No 178\/2002 and Regulation (EC) No 1223\/2009 and Repealing Council Directives 90\/385\/EEC and 93\/42\/EEC [2017] OJ L 117\/1, Art 51."},{"key":"2026091704450875000_2.1.e000105.5","unstructured":"Medical Device Coordination Group (MDCG) . MDCG 2023-1 Guidance on the Health Institution Exemption under Article 5(5) of Regulation (EU) 2017\/745 and Regulation (EU) 2017\/746."},{"key":"2026091704450875000_2.1.e000105.6","unstructured":"European Commission . In-House Medical Devices. European Commission \u2013 Public Health. Available: https:\/\/health.ec.europa.eu\/medical-devices-topics-interest\/house-medical-devices_en [Accessed 14 Apr 2026]."},{"key":"2026091704450875000_2.1.e000105.7","doi-asserted-by":"crossref","first-page":"111852","DOI":"10.1016\/j.ejrad.2024.111852","article-title":"The translation of in-house imaging AI research into a medical device ensuring ethical and regulatory integrity","volume":"182","author":"Pesapane","year":"2025","journal-title":"Eur J Radiol"},{"key":"2026091704450875000_2.1.e000105.8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1163\/15718093-bja10104","article-title":"A Blanket That Leaves the Feet Cold: Exploring the AI Act Safety Framework for Medical AI","volume":"30","author":"Palmieri","year":"2023","journal-title":"Eur J Health Law"},{"key":"2026091704450875000_2.1.e000105.9","unstructured":"Palmieri S . The Renewed EU Legal Framework for Medical AI. Eur J Health Law 2024;15. Available: https:\/\/ejlt.org\/index.php\/ejlt\/article\/view\/969"},{"key":"2026091704450875000_2.1.e000105.10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41746-024-01232-3","article-title":"Navigating the EU AI Act: implications for regulated digital medical products","volume":"7","author":"Aboy","year":"2024","journal-title":"npj Digit Med"},{"key":"2026091704450875000_2.1.e000105.11","doi-asserted-by":"crossref","DOI":"10.1038\/s44401-026-00104-0","article-title":"AI literacy in healthcare organisations: implementing article 4 of the EU AI Act with M-SHALF","volume":"3","author":"Palmieri","year":"2026","journal-title":"Npj Health Syst"},{"key":"2026091704450875000_2.1.e000105.12","unstructured":"Regulation (EU) 2026\/1744 of the European Parliament and of the Council of 8 July 2026 Amending Regulations (EU) 2024\/1689, (EU) 2018\/1139 and (EU) 2023\/1230 as Regards the Simplification of the Implementation of Harmonised Rules on Artificial Intelligence (Digital Omnibus on AI) [2026] OJ L 2026\/1744."},{"key":"2026091704450875000_2.1.e000105.13","unstructured":"European Commission . Proposal for a Regulation of the European Parliament and of the Council Amending Regulations (EU) 2017\/745 and (EU) 2017\/746 as Regards Simplifying and Reducing the Burden of the Rules on Medical Devices and in Vitro Diagnostic Medical Devices, and Amending Regulations (EU) 2022\/123 and (EU) 2024\/1689, COM(2025) 1023 Final, 16 December 2025, 2025\/0404(COD)."},{"key":"2026091704450875000_2.1.e000105.14","unstructured":"European Parliament . Legislative Observatory, Procedure 2025\/0404(COD), Medical Devices and in Vitro Diagnostic Medical Devices: Simplifying and Reducing the Burden of the Rules, Status: Awaiting Committee Decision. 2026."},{"key":"2026091704450875000_2.1.e000105.15","unstructured":"Interplay between the Medical Devices Regulation (MDR) &amp; In Vitro Diagnostic Medical Devices Regulation (IVDR) and the Artificial Intelligence Act (AIA). Medical Device Coordination Group (MDCG) and Artificial Intelligence Board (AIB); 2025."},{"key":"2026091704450875000_2.1.e000105.16","unstructured":"Palmieri S , Nolte H . Simplification or Back to Square One? The Future of EU Medical AI Regulation. Bill of Health 2026. Available: https:\/\/petrieflom.law.harvard.edu\/2026\/03\/05\/simplification-or-back-to-square-one-the-future-of-eu-medical-ai-regulation\/"},{"key":"2026091704450875000_2.1.e000105.17","unstructured":"European Commission . Proposal for a Regulation to Simplify Rules on Medical and in Vitro Diagnostic Devices. 2026."},{"key":"2026091704450875000_2.1.e000105.18","unstructured":"Biomedical Alliance in Europe . Review of the EU Medical Device Regulations. 2025. Available: https:\/\/Www.Biomedeurope.Org\/Wp-Content\/Uploads\/2025\/03\/BioMed-Recommendations-MDR-IVDR-2025-002.Pdf [Accessed 7 Apr 2026]."},{"key":"2026091704450875000_2.1.e000105.19","unstructured":"International medical device regulators forum . \u201cSoftware as a Medical Device\u201d: Possible Framework for Risk Categorization and Corresponding Considerations. IMDRF SaMD Working Group, Available: https:\/\/www.imdrf.org\/documents\/software-medical-device-possible-framework-risk-categorization-and-corresponding-considerations [accessed 14 Apr 2026]."},{"key":"2026091704450875000_2.1.e000105.20","unstructured":"International Medical Device Regulators Forum . Software as a Medical Device (SaMD): Key Definitions. IMDRF SaMD Working Group. Available: http:\/\/Www.Imdrf.Org\/Docs\/Imdrf\/Final\/Technical\/Imdrf-Tech-131209-Samd-Key-Definitions-140901.Pdf [accessed 14 Apr 2026]."},{"key":"2026091704450875000_2.1.e000105.21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.36644\/mlr.116.3.regulating","article-title":"Regulating Black-Box Medicine","volume":"116","author":"Price","year":"2017","journal-title":"MLR"},{"key":"2026091704450875000_2.1.e000105.22","unstructured":"US Food and Drug Administration . Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff. Silver Spring (MD): FDA; 2026."},{"key":"2026091704450875000_2.1.e000105.23","unstructured":"U.S. Food and Drug Administration . Changes to Existing Medical Software Policies Resulting from Section 3060 of the 21st Century Cures Act: Guidance for Industry and Food and Drug Administration Staff. Silver Spring (MD) FDA. Available: https:\/\/Www.Fda.Gov\/Media\/109622\/Download [accessed 14 Apr 2026]"},{"key":"2026091704450875000_2.1.e000105.24","unstructured":"U.S. Food and Drug Administration . FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled Medical Devices [News Release]. Silver Spring (MD): FDA; 2025."},{"key":"2026091704450875000_2.1.e000105.25","unstructured":"U.S. Food and Drug Administration . Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations: Draft Guidance for Industry and Food and Drug Administration Staff. Silver Spring (MD): FDA; 2025."},{"key":"2026091704450875000_2.1.e000105.26","unstructured":"U.S. Food and Drug Administration . Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions: Guidance for Industry and Food and Drug Administration Staff. Silver Spring (MD): FDA; 2025."},{"key":"2026091704450875000_2.1.e000105.27","doi-asserted-by":"crossref","first-page":"01","DOI":"10.70315\/uloap.ulete.2025.0201001","article-title":"Compliance or Innovation? The Balancing Act for Startups Under the AI Act","volume":"02","author":"Davalas","year":"2025","journal-title":"ULETE"},{"key":"2026091704450875000_2.1.e000105.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMhle2308901"},{"key":"2026091704450875000_2.1.e000105.29","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2024.00842"},{"key":"2026091704450875000_2.1.e000105.30","doi-asserted-by":"crossref","DOI":"10.2196\/32679","article-title":"The Role of Academic Health Systems in Leading the \u201cThird Wave\u201d of Digital Health Innovation","volume":"8","author":"Faruki","year":"2022","journal-title":"JMIR Med Educ"},{"key":"2026091704450875000_2.1.e000105.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.0887-378X.2004.00325.x"},{"key":"2026091704450875000_2.1.e000105.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.15.1969"},{"key":"2026091704450875000_2.1.e000105.33","unstructured":"Coalition for Health AI (CHAI) . Applied Model Card Workgroup. 2026. Available: https:\/\/Www.Chai.Org\/Workgroup\/Applied-Model [Accessed 14 Apr 2026]."},{"key":"2026091704450875000_2.1.e000105.34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/17579961.2023.2245678","article-title":"Regulatory sandboxes in the AI Act: reconciling innovation and safety?","volume":"15","author":"Buocz","year":"2023","journal-title":"Law Innov Technol"}],"container-title":["BMJ Digital Health &amp; AI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdh-2026-000105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:45:37Z","timestamp":1789645537000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjdigitalhealth.bmj.com\/lookup\/doi\/10.1136\/bmjdh-2026-000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,9,17]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjdh-2026-000105"],"URL":"https:\/\/doi.org\/10.1136\/bmjdh-2026-000105","relation":{},"ISSN":["3049-575X"],"issn-type":[{"value":"3049-575X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}